stoxline Quote Chart Rank Option Currency Glossary
Ortho Clinical Diagnostics Holdings plc (OCDX)
17.63  0.16 (0.92%)    12-31 19:00
Open: 17.68
High: 17.71
Volume: 789,491
Pre. Close: 17.47
Low: 17.36
Market Cap: 0(M)
Technical analysis
2022-11-18 4:23:17 PM
Short term     
Mid term     
Targets 6-month :  20.68 1-year :  24.16
Resists First :  17.7 Second :  20.68
Pivot price 17.62
Supports First :  17.49 Second :  17.36
MAs MA(5) :  17.62 MA(20) :  17.62
MA(100) :  17.62 MA(250) :  17.97
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  77.1 D(3) :  77.1
RSI RSI(14): 49.3
52-week High :  21.52 Low :  16.04
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ OCDX ] has closed Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 17.75 - 17.84 17.84 - 17.91
Low: 17.12 - 17.24 17.24 - 17.33
Close: 17.46 - 17.64 17.64 - 17.79
Company Description

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Headline News

Fri, 01 Dec 2023
J&J Sells Ortho-Clinical for $4 Billion - MD+DI

Fri, 27 May 2022
Quidel, Ortho Clinical Diagnostics combine to form diagnostics company - Mass Device

Thu, 26 May 2022
Quidel and Ortho Announce Expected Closing of Ortho Transaction - Business Wire

Tue, 08 Mar 2022
Ortho Clinical: Uncertain Merger & Inflation Environment (NASDAQ:OCDX) - Seeking Alpha

Fri, 18 Feb 2022
Anchorage Capital Group, L.L.C. Buys SentinelOne Inc, SentinelOn -

Tue, 28 Dec 2021
Quidel Corporation Acquires Ortho Clinical Diagnostics for $6B - HIT Consultant

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Diagnostics & Research
Shares Out 238 (M)
Shares Float 119 (M)
Held by Insiders 0.3 (%)
Held by Institutions 98.3 (%)
Shares Short 7,020 (K)
Shares Short P.Month 6,800 (K)
Stock Financials
EPS -0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.87
Profit Margin -0.1 %
Operating Margin 8.4 %
Return on Assets (ttm) 3.2 %
Return on Equity (ttm) -0.2 %
Qtrly Rev. Growth -1.3 %
Gross Profit (p.s.) 4.37
Sales Per Share 8.58
EBITDA (p.s.) 1.89
Qtrly Earnings Growth 0 %
Operating Cash Flow 293 (M)
Levered Free Cash Flow 400 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0.4
Price to Book value 9.42
Price to Sales 2.05
Price to Cash Flow 14.32
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android